Original language | English |
---|---|
Pages (from-to) | 18-19 |
Number of pages | 2 |
Journal | Multiple Sclerosis |
Volume | 21 |
Issue number | Supp: 11 |
DOIs | |
Publication status | Published - Sept 2015 |
Event | 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Barcelona, Spain Duration: 7 Oct 2015 → 10 Oct 2015 Conference number: 31 |
MS FIRST - utilising a drug safety module for use in MS clinical practice to evaluate lymphocyte reduction in fingolimod treatment over time, demographic predictors of lymphopenia and association with reported safety events
Jodi Haartsen, S. Agland, J Baker, T Burke, L Rath, Jeannette Lechner-Scott, B Taylor, Steve Vucic, M Barnett, Mark Slee, S. Hodgkinson, Olga Skibina, Allan Kermode, E. Butler, Neil Shuey, C Shaw, Tristan Hardy, I. L. Tan, H Butzkueven, Tim Spelman
Research output: Contribution to journal › Meeting Abstract › peer-review